Literature DB >> 21193684

Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents.

Dylan M Williams1, Abigail Fraser, Debbie A Lawlor.   

Abstract

OBJECTIVE: To examine independent associations of serum 25-hydroxyvitamin D (25(OH)D), parathyroid hormone (PTH) and calcium with a range of cardiovascular risk factors in adolescents.
DESIGN: Cross-sectional population-based study.
SETTING: A nationally representative sample of the US adolescent population. PARTICIPANTS: Healthy adolescents (aged 12-19) participating in the National Health and Nutrition Examination Survey (NHANES) between 2001 and 2006. Numbers varied between 740 and 5609 for given exposure and outcome associations. MAIN OUTCOME MEASURES: Systolic blood pressure (SBP), diastolic blood pressure (DBP), lipids (triglycerides, low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C)), fasting insulin and glucose, postload glucose and glycohaemoglobin (HbA1c).
RESULTS: 25(OH)D was inversely associated with SBP (-0.068 standard deviations (SD), 95% CI -0.118 to -0.018), and positively associated with HDL-C (0.101; 0.040 to 0.162) and HbA1c (0.073; 0.021 to 0.125) after adjustment for gender, age, ethnicity, socioeconomic status and waist circumference. In adjusted models, PTH was inversely associated with triglycerides (-0.115; -0.188 to -0.042) and LDL-C (-0.133; -0.207 to -0.060). In adjusted models, calcium was positively associated with fasting insulin (0.110; 0.060 to 0.160), postload glucose (0.116; 0.000 to 0.232), HbA1c (0.079; 0.035 to 0.123), triglycerides (0.182; 0.122 to 0.242), HDL-C (0.049; 0.010 to 0.088) and LDL-C (0.137; 0.080 to 0.195). The associations of each exposure with risk factors remained after mutual adjustment for each other.
CONCLUSION: Higher calcium levels might be a more important predictor of increased cardiovascular risk in adolescents than lower 25(OH)D levels or PTH levels, but the findings require replication in additional studies and examination in prospective studies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193684      PMCID: PMC3931194          DOI: 10.1136/hrt.2010.203224

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  29 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  Ultraviolet B and blood pressure.

Authors:  R Krause; M Bühring; W Hopfenmüller; M F Holick; A M Sharma
Journal:  Lancet       Date:  1998-08-29       Impact factor: 79.321

3.  Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years.

Authors:  L Lind; E Skarfors; L Berglund; H Lithell; S Ljunghall
Journal:  J Clin Epidemiol       Date:  1997-08       Impact factor: 6.437

4.  Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women.

Authors:  M Pfeifer; B Begerow; H W Minne; D Nachtigall; C Hansen
Journal:  J Clin Endocrinol Metab       Date:  2001-04       Impact factor: 5.958

5.  Vitamin D status and cardiometabolic risk factors in the United States adolescent population.

Authors:  Jared P Reis; Denise von Mühlen; Edgar R Miller; Erin D Michos; Lawrence J Appel
Journal:  Pediatrics       Date:  2009-08-03       Impact factor: 7.124

6.  Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women.

Authors:  Marieke B Snijder; Rob M van Dam; Marjolein Visser; Dorly J H Deeg; Jacqueline M Dekker; Lex M Bouter; Jaap C Seidell; Paul Lips
Journal:  J Clin Endocrinol Metab       Date:  2005-04-26       Impact factor: 5.958

7.  Vitamin D deficiency inhibits pancreatic secretion of insulin.

Authors:  A W Norman; J B Frankel; A M Heldt; G M Grodsky
Journal:  Science       Date:  1980-08-15       Impact factor: 47.728

8.  Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: insights from simulations based on serum 25-hydroxyvitamin d.

Authors:  Yiting Wang; Eric J Jacobs; Marjorie L McCullough; Carmen Rodriguez; Michael J Thun; Eugenia E Calle; W Dana Flanders
Journal:  Am J Epidemiol       Date:  2009-04-30       Impact factor: 4.897

9.  Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.

Authors:  Emil Hagström; Per Hellman; Tobias E Larsson; Erik Ingelsson; Lars Berglund; Johan Sundström; Håkan Melhus; Claes Held; Lars Lind; Karl Michaëlsson; Johan Arnlöv
Journal:  Circulation       Date:  2009-05-18       Impact factor: 29.690

10.  Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers.

Authors:  Armin Zittermann; Sabine Frisch; Heiner K Berthold; Christian Götting; Joachim Kuhn; Knut Kleesiek; Peter Stehle; Heinrich Koertke; Reiner Koerfer
Journal:  Am J Clin Nutr       Date:  2009-03-25       Impact factor: 7.045

View more
  16 in total

Review 1.  Almanac 2013: stable coronary artery disease.

Authors:  Shahed Islam; Adam Timmis
Journal:  Wien Klin Wochenschr       Date:  2013-12       Impact factor: 1.704

2.  Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study).

Authors:  Adriana J van Ballegooijen; Marjolein Visser; Bryan Kestenbaum; David S Siscovick; Ian H de Boer; John S Gottdiener; Christopher R deFilippi; Ingeborg A Brouwer
Journal:  Am J Cardiol       Date:  2012-11-17       Impact factor: 2.778

3.  Association of bone metabolism markers with coronary atherosclerosis and coronary artery disease in postmenopausal women.

Authors:  Yan Ling; Zhen Wang; Bingjie Wu; Xin Gao
Journal:  J Bone Miner Metab       Date:  2017-06-22       Impact factor: 2.626

4.  High prevalence of vitamin D insufficiency/deficiency in Dutch multi-ethnic obese children.

Authors:  Nalini Radhakishun; Mariska van Vliet; Ines von Rosenstiel; Olivier Weijer; Michaela Diamant; Jos Beijnen; Dees Brandjes
Journal:  Eur J Pediatr       Date:  2015-02       Impact factor: 3.183

Review 5.  Potential pathophysiological role for the vitamin D deficiency in essential hypertension.

Authors:  Federico Carbone; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  World J Cardiol       Date:  2014-05-26

6.  Relationship between 25 hydroxyvitamin D and lipid profile in Lebanese school children.

Authors:  M H Gannagé-Yared; R Sabbagh; R Chédid
Journal:  J Endocrinol Invest       Date:  2018-02-06       Impact factor: 4.256

7.  Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children.

Authors:  Dylan M Williams; Abigail Fraser; Adrian Sayers; William D Fraser; Aroon Hingorani; John Deanfield; George Davey Smith; Naveed Sattar; Debbie A Lawlor
Journal:  J Clin Endocrinol Metab       Date:  2012-02-16       Impact factor: 5.958

8.  Associations of childhood 25-hydroxyvitamin D2 and D3 and cardiovascular risk factors in adolescence: prospective findings from the Avon Longitudinal Study of Parents and Children.

Authors:  Dylan M Williams; Abigail Fraser; Adrian Sayers; William D Fraser; Elina Hyppönen; George Davey Smith; Naveed Sattar; Debbie A Lawlor
Journal:  Eur J Prev Cardiol       Date:  2012-11-26       Impact factor: 7.804

9.  Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links.

Authors:  A Fisher; W Srikusalanukul; M Davis; P Smith
Journal:  Clin Interv Aging       Date:  2013-02-25       Impact factor: 4.458

10.  Differences and associations of metabolic and vitamin D status among patients with and without sub-clinical hypothyroid dysfunction.

Authors:  Naji J Aljohani; Nasser M Al-Daghri; Omar S Al-Attas; Majed S Alokail; Khalid M Alkhrafy; Abdulaziz Al-Othman; Sobhy Yakout; Abdulaziz F Alkabba; Ahmed S Al-Ghamdi; Mussa Almalki; Badurudeen Mahmood Buhary; Shaun Sabico
Journal:  BMC Endocr Disord       Date:  2013-08-20       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.